NCT00262457

Brief Summary

The purpose of this study was to determine the feasibility of an implanted electrical stimulation system incorporating BION microstimulators for long term use to prevent tissue breakdown in high risk patients.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2004

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

December 2, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 6, 2005

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
Last Updated

September 17, 2013

Status Verified

September 1, 2013

Enrollment Period

3.8 years

First QC Date

December 2, 2005

Last Update Submit

September 16, 2013

Conditions

Keywords

electrical stimulationPressure UlcersSpinal Cord Injury

Outcome Measures

Primary Outcomes (1)

  • Improvement of tissue health

    Not feasible

Study Arms (1)

Arm 1

OTHER
Device: Implanted gluteal electrical stimulation system

Interventions

Implanted electrical stimulation system incorporating BION microstimulators

Arm 1

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Motor and sensory complete spinal cord injury above the level T12.
  • No open skin problems or hospitalizations during the three months prior to entrance into the study.

You may not qualify if:

  • Age less than 18 years.
  • Less than two years post-injury or loss of independent walking ability.
  • More than three urinary tract infections in the previous year.
  • Significant active systemic disease, e.g. heart disease, renal failure, diabetes.
  • Abnormal nutritional status based on albumin and total protein levels at recruitment (3.0 for albumin, 6.0 for total protein).
  • Osteomyelitis of the pelvic region, indicated by positive pelvic inlet X-ray from routine annual urologic examination or bone scan.
  • Previous surgery in the perineal region that radically alters the basic anatomy, particularly regional innervation and blood supply, e.g. amputation, hemipelvectomy.
  • Extensive lower motor neuron damage to motor nerves innervating the gluteal muscles or electrical excitability of gluteal muscles with lower motor neuron innervation insufficient to produce desired level of contraction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Medical Center, Cleveland

Cleveland, Ohio, 44106, United States

Location

Related Links

MeSH Terms

Conditions

Pressure UlcerSpinal Cord Injuries

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Kath M. Bogie, PhD

    VA Medical Center-Cleveland

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2005

First Posted

December 6, 2005

Study Start

April 1, 2004

Primary Completion

February 1, 2008

Study Completion

February 1, 2008

Last Updated

September 17, 2013

Record last verified: 2013-09

Locations